Global Nuclear Medicine/Radiopharmaceutic Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nuclear Medicine/Radiopharmaceutic Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Nuclear Medicine/Radiopharmaceutic by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Nuclear Medicine/Radiopharmaceutic by Country/Region, 2017, 2022 & 2028

2.2 Nuclear Medicine/Radiopharmaceutic Segment by Type

2.2.1 Tc-99

2.2.2 I-123/131

2.2.3 In-111

2.2.4 Xe-133

2.2.5 Th-201

2.2.6 Ga-67

2.2.7 Other

2.3 Nuclear Medicine/Radiopharmaceutic Sales by Type

2.3.1 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2022)

2.3.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Type (2017-2022)

2.3.3 Global Nuclear Medicine/Radiopharmaceutic Sale Price by Type (2017-2022)

2.4 Nuclear Medicine/Radiopharmaceutic Segment by Application

2.4.1 Diagnostic

2.4.2 Therapeutic

2.5 Nuclear Medicine/Radiopharmaceutic Sales by Application

2.5.1 Global Nuclear Medicine/Radiopharmaceutic Sale Market Share by Application (2017-2022)

2.5.2 Global Nuclear Medicine/Radiopharmaceutic Revenue and Market Share by Application (2017-2022)

2.5.3 Global Nuclear Medicine/Radiopharmaceutic Sale Price by Application (2017-2022)

3 Global Nuclear Medicine/Radiopharmaceutic by Company

3.1 Global Nuclear Medicine/Radiopharmaceutic Breakdown Data by Company

3.1.1 Global Nuclear Medicine/Radiopharmaceutic Annual Sales by Company (2020-2022)

3.1.2 Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2020-2022)

3.2 Global Nuclear Medicine/Radiopharmaceutic Annual Revenue by Company (2020-2022)

3.2.1 Global Nuclear Medicine/Radiopharmaceutic Revenue by Company (2020-2022)

3.2.2 Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2020-2022)

3.3 Global Nuclear Medicine/Radiopharmaceutic Sale Price by Company

3.4 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nuclear Medicine/Radiopharmaceutic Product Location Distribution

3.4.2 Players Nuclear Medicine/Radiopharmaceutic Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nuclear Medicine/Radiopharmaceutic by Geographic Region

4.1 World Historic Nuclear Medicine/Radiopharmaceutic Market Size by Geographic Region (2017-2022)

4.1.1 Global Nuclear Medicine/Radiopharmaceutic Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Nuclear Medicine/Radiopharmaceutic Annual Revenue by Geographic Region

4.2 World Historic Nuclear Medicine/Radiopharmaceutic Market Size by Country/Region (2017-2022)

4.2.1 Global Nuclear Medicine/Radiopharmaceutic Annual Sales by Country/Region (2017-2022)

4.2.2 Global Nuclear Medicine/Radiopharmaceutic Annual Revenue by Country/Region

4.3 Americas Nuclear Medicine/Radiopharmaceutic Sales Growth

4.4 APAC Nuclear Medicine/Radiopharmaceutic Sales Growth

4.5 Europe Nuclear Medicine/Radiopharmaceutic Sales Growth

4.6 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Growth

5 Americas

5.1 Americas Nuclear Medicine/Radiopharmaceutic Sales by Country

5.1.1 Americas Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022)

5.1.2 Americas Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022)

5.2 Americas Nuclear Medicine/Radiopharmaceutic Sales by Type

5.3 Americas Nuclear Medicine/Radiopharmaceutic Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nuclear Medicine/Radiopharmaceutic Sales by Region

6.1.1 APAC Nuclear Medicine/Radiopharmaceutic Sales by Region (2017-2022)

6.1.2 APAC Nuclear Medicine/Radiopharmaceutic Revenue by Region (2017-2022)

6.2 APAC Nuclear Medicine/Radiopharmaceutic Sales by Type

6.3 APAC Nuclear Medicine/Radiopharmaceutic Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Nuclear Medicine/Radiopharmaceutic by Country

7.1.1 Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022)

7.1.2 Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022)

7.2 Europe Nuclear Medicine/Radiopharmaceutic Sales by Type

7.3 Europe Nuclear Medicine/Radiopharmaceutic Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic by Country

8.1.1 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022)

8.1.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022)

8.2 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Type

8.3 Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Nuclear Medicine/Radiopharmaceutic

10.3 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

10.4 Industry Chain Structure of Nuclear Medicine/Radiopharmaceutic

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Nuclear Medicine/Radiopharmaceutic Distributors

11.3 Nuclear Medicine/Radiopharmaceutic Customer

12 World Forecast Review for Nuclear Medicine/Radiopharmaceutic by Geographic Region

12.1 Global Nuclear Medicine/Radiopharmaceutic Market Size Forecast by Region

12.1.1 Global Nuclear Medicine/Radiopharmaceutic Forecast by Region (2023-2028)

12.1.2 Global Nuclear Medicine/Radiopharmaceutic Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Nuclear Medicine/Radiopharmaceutic Forecast by Type

12.7 Global Nuclear Medicine/Radiopharmaceutic Forecast by Application

13 Key Players Analysis

13.1 GE Healthcare

13.1.1 GE Healthcare Company Information

13.1.2 GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Offered

13.1.3 GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 GE Healthcare Main Business Overview

13.1.5 GE Healthcare Latest Developments

13.2 Bracco Imaging

13.2.1 Bracco Imaging Company Information

13.2.2 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Offered

13.2.3 Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Bracco Imaging Main Business Overview

13.2.5 Bracco Imaging Latest Developments

13.3 Mallinckrodt

13.3.1 Mallinckrodt Company Information

13.3.2 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Offered

13.3.3 Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Mallinckrodt Main Business Overview

13.3.5 Mallinckrodt Latest Developments

13.4 Lantheus Medical Imaging

13.4.1 Lantheus Medical Imaging Company Information

13.4.2 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Offered

13.4.3 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Lantheus Medical Imaging Main Business Overview

13.4.5 Lantheus Medical Imaging Latest Developments

13.5 Bayer

13.5.1 Bayer Company Information

13.5.2 Bayer Nuclear Medicine/Radiopharmaceutic Product Offered

13.5.3 Bayer Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Bayer Main Business Overview

13.5.5 Bayer Latest Developments

13.6 Jubilant Pharma

13.6.1 Jubilant Pharma Company Information

13.6.2 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Offered

13.6.3 Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Jubilant Pharma Main Business Overview

13.6.5 Jubilant Pharma Latest Developments

13.7 Nordion

13.7.1 Nordion Company Information

13.7.2 Nordion Nuclear Medicine/Radiopharmaceutic Product Offered

13.7.3 Nordion Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Nordion Main Business Overview

13.7.5 Nordion Latest Developments

13.8 Eli Lilly

13.8.1 Eli Lilly Company Information

13.8.2 Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Offered

13.8.3 Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Eli Lilly Main Business Overview

13.8.5 Eli Lilly Latest Developments

13.9 SIEMENS

13.9.1 SIEMENS Company Information

13.9.2 SIEMENS Nuclear Medicine/Radiopharmaceutic Product Offered

13.9.3 SIEMENS Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 SIEMENS Main Business Overview

13.9.5 SIEMENS Latest Developments

13.10 China Isotope & Radiation

13.10.1 China Isotope & Radiation Company Information

13.10.2 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Offered

13.10.3 China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 China Isotope & Radiation Main Business Overview

13.10.5 China Isotope & Radiation Latest Developments

13.11 Yantai Dongcheng Biochemicals

13.11.1 Yantai Dongcheng Biochemicals Company Information

13.11.2 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Offered

13.11.3 Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Yantai Dongcheng Biochemicals Main Business Overview

13.11.5 Yantai Dongcheng Biochemicals Latest Developments

14 Research Findings and Conclusion

Table 1. Nuclear Medicine/Radiopharmaceutic Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Nuclear Medicine/Radiopharmaceutic Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Tc-99

Table 4. Major Players of I-123/131

Table 5. Major Players of In-111

Table 6. Major Players of Xe-133

Table 7. Major Players of Th-201

Table 8. Major Players of Ga-67

Table 9. Major Players of Other

Table 10. Global Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)

Table 11. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2022)

Table 12. Global Nuclear Medicine/Radiopharmaceutic Revenue by Type (2017-2022) & ($ million)

Table 13. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2017-2022)

Table 14. Global Nuclear Medicine/Radiopharmaceutic Sale Price by Type (2017-2022) & (US$/Ton)

Table 15. Global Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)

Table 16. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

Table 17. Global Nuclear Medicine/Radiopharmaceutic Revenue by Application (2017-2022)

Table 18. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application (2017-2022)

Table 19. Global Nuclear Medicine/Radiopharmaceutic Sale Price by Application (2017-2022) & (US$/Ton)

Table 20. Global Nuclear Medicine/Radiopharmaceutic Sales by Company (2020-2022) & (Kiloton)

Table 21. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Company (2020-2022)

Table 22. Global Nuclear Medicine/Radiopharmaceutic Revenue by Company (2020-2022) ($ Millions)

Table 23. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company (2020-2022)

Table 24. Global Nuclear Medicine/Radiopharmaceutic Sale Price by Company (2020-2022) & (US$/Ton)

Table 25. Key Manufacturers Nuclear Medicine/Radiopharmaceutic Producing Area Distribution and Sales Area

Table 26. Players Nuclear Medicine/Radiopharmaceutic Products Offered

Table 27. Nuclear Medicine/Radiopharmaceutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 28. New Products and Potential Entrants

Table 29. Mergers & Acquisitions, Expansion

Table 30. Global Nuclear Medicine/Radiopharmaceutic Sales by Geographic Region (2017-2022) & (Kiloton)

Table 31. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Geographic Region (2017-2022)

Table 32. Global Nuclear Medicine/Radiopharmaceutic Revenue by Geographic Region (2017-2022) & ($ millions)

Table 33. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Geographic Region (2017-2022)

Table 34. Global Nuclear Medicine/Radiopharmaceutic Sales by Country/Region (2017-2022) & (Kiloton)

Table 35. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country/Region (2017-2022)

Table 36. Global Nuclear Medicine/Radiopharmaceutic Revenue by Country/Region (2017-2022) & ($ millions)

Table 37. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country/Region (2017-2022)

Table 38. Americas Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)

Table 39. Americas Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2017-2022)

Table 40. Americas Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022) & ($ Millions)

Table 41. Americas Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2017-2022)

Table 42. Americas Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)

Table 43. Americas Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2022)

Table 44. Americas Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)

Table 45. Americas Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

Table 46. APAC Nuclear Medicine/Radiopharmaceutic Sales by Region (2017-2022) & (Kiloton)

Table 47. APAC Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2017-2022)

Table 48. APAC Nuclear Medicine/Radiopharmaceutic Revenue by Region (2017-2022) & ($ Millions)

Table 49. APAC Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Region (2017-2022)

Table 50. APAC Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)

Table 51. APAC Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2022)

Table 52. APAC Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)

Table 53. APAC Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

Table 54. Europe Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)

Table 55. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2017-2022)

Table 56. Europe Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022) & ($ Millions)

Table 57. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2017-2022)

Table 58. Europe Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)

Table 59. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2022)

Table 60. Europe Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)

Table 61. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

Table 62. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Country (2017-2022) & (Kiloton)

Table 63. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country (2017-2022)

Table 64. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue by Country (2017-2022) & ($ Millions)

Table 65. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country (2017-2022)

Table 66. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Type (2017-2022) & (Kiloton)

Table 67. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type (2017-2022)

Table 68. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales by Application (2017-2022) & (Kiloton)

Table 69. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

Table 70. Key Market Drivers & Growth Opportunities of Nuclear Medicine/Radiopharmaceutic

Table 71. Key Market Challenges & Risks of Nuclear Medicine/Radiopharmaceutic

Table 72. Key Industry Trends of Nuclear Medicine/Radiopharmaceutic

Table 73. Nuclear Medicine/Radiopharmaceutic Raw Material

Table 74. Key Suppliers of Raw Materials

Table 75. Nuclear Medicine/Radiopharmaceutic Distributors List

Table 76. Nuclear Medicine/Radiopharmaceutic Customer List

Table 77. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2023-2028) & (Kiloton)

Table 78. Global Nuclear Medicine/Radiopharmaceutic Sales Market Forecast by Region

Table 79. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Region (2023-2028)

Table 81. Americas Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2023-2028) & (Kiloton)

Table 82. Americas Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. APAC Nuclear Medicine/Radiopharmaceutic Sales Forecast by Region (2023-2028) & (Kiloton)

Table 84. APAC Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Region (2023-2028) & ($ millions)

Table 85. Europe Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2023-2028) & (Kiloton)

Table 86. Europe Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Forecast by Country (2023-2028) & (Kiloton)

Table 88. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Country (2023-2028) & ($ millions)

Table 89. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Type (2023-2028) & (Kiloton)

Table 90. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Type (2023-2028)

Table 91. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 92. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Type (2023-2028)

Table 93. Global Nuclear Medicine/Radiopharmaceutic Sales Forecast by Application (2023-2028) & (Kiloton)

Table 94. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share Forecast by Application (2023-2028)

Table 95. Global Nuclear Medicine/Radiopharmaceutic Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 96. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share Forecast by Application (2023-2028)

Table 97. GE Healthcare Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 98. GE Healthcare Nuclear Medicine/Radiopharmaceutic Product Offered

Table 99. GE Healthcare Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 100. GE Healthcare Main Business

Table 101. GE Healthcare Latest Developments

Table 102. Bracco Imaging Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 103. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Product Offered

Table 104. Bracco Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 105. Bracco Imaging Main Business

Table 106. Bracco Imaging Latest Developments

Table 107. Mallinckrodt Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 108. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Product Offered

Table 109. Mallinckrodt Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 110. Mallinckrodt Main Business

Table 111. Mallinckrodt Latest Developments

Table 112. Lantheus Medical Imaging Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 113. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Product Offered

Table 114. Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 115. Lantheus Medical Imaging Main Business

Table 116. Lantheus Medical Imaging Latest Developments

Table 117. Bayer Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 118. Bayer Nuclear Medicine/Radiopharmaceutic Product Offered

Table 119. Bayer Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 120. Bayer Main Business

Table 121. Bayer Latest Developments

Table 122. Jubilant Pharma Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 123. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Product Offered

Table 124. Jubilant Pharma Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 125. Jubilant Pharma Main Business

Table 126. Jubilant Pharma Latest Developments

Table 127. Nordion Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 128. Nordion Nuclear Medicine/Radiopharmaceutic Product Offered

Table 129. Nordion Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 130. Nordion Main Business

Table 131. Nordion Latest Developments

Table 132. Eli Lilly Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 133. Eli Lilly Nuclear Medicine/Radiopharmaceutic Product Offered

Table 134. Eli Lilly Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 135. Eli Lilly Main Business

Table 136. Eli Lilly Latest Developments

Table 137. SIEMENS Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 138. SIEMENS Nuclear Medicine/Radiopharmaceutic Product Offered

Table 139. SIEMENS Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 140. SIEMENS Main Business

Table 141. SIEMENS Latest Developments

Table 142. China Isotope & Radiation Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 143. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Product Offered

Table 144. China Isotope & Radiation Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 145. China Isotope & Radiation Main Business

Table 146. China Isotope & Radiation Latest Developments

Table 147. Yantai Dongcheng Biochemicals Basic Information, Nuclear Medicine/Radiopharmaceutic Manufacturing Base, Sales Area and Its Competitors

Table 148. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Product Offered

Table 149. Yantai Dongcheng Biochemicals Nuclear Medicine/Radiopharmaceutic Sales (Kiloton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2020-2022)

Table 150. Yantai Dongcheng Biochemicals Main Business

Table 151. Yantai Dongcheng Biochemicals Latest Developments

List of Figures

Figure 1. Picture of Nuclear Medicine/Radiopharmaceutic

Figure 2. Nuclear Medicine/Radiopharmaceutic Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nuclear Medicine/Radiopharmaceutic Sales Growth Rate 2017-2028 (Kiloton)

Figure 7. Global Nuclear Medicine/Radiopharmaceutic Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Nuclear Medicine/Radiopharmaceutic Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Tc-99

Figure 10. Product Picture of I-123/131

Figure 11. Product Picture of In-111

Figure 12. Product Picture of Xe-133

Figure 13. Product Picture of Th-201

Figure 14. Product Picture of Ga-67

Figure 15. Product Picture of Other

Figure 16. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Type in 2021

Figure 17. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Type (2017-2022)

Figure 18. Nuclear Medicine/Radiopharmaceutic Consumed in Diagnostic

Figure 19. Global Nuclear Medicine/Radiopharmaceutic Market: Diagnostic (2017-2022) & (Kiloton)

Figure 20. Nuclear Medicine/Radiopharmaceutic Consumed in Therapeutic

Figure 21. Global Nuclear Medicine/Radiopharmaceutic Market: Therapeutic (2017-2022) & (Kiloton)

Figure 22. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Application (2017-2022)

Figure 23. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Application in 2021

Figure 24. Nuclear Medicine/Radiopharmaceutic Revenue Market by Company in 2021 ($ Million)

Figure 25. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Company in 2021

Figure 26. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Geographic Region (2017-2022)

Figure 27. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Geographic Region in 2021

Figure 28. Global Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region (2017-2022)

Figure 29. Global Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country/Region in 2021

Figure 30. Americas Nuclear Medicine/Radiopharmaceutic Sales 2017-2022 (Kiloton)

Figure 31. Americas Nuclear Medicine/Radiopharmaceutic Revenue 2017-2022 ($ Millions)

Figure 32. APAC Nuclear Medicine/Radiopharmaceutic Sales 2017-2022 (Kiloton)

Figure 33. APAC Nuclear Medicine/Radiopharmaceutic Revenue 2017-2022 ($ Millions)

Figure 34. Europe Nuclear Medicine/Radiopharmaceutic Sales 2017-2022 (Kiloton)

Figure 35. Europe Nuclear Medicine/Radiopharmaceutic Revenue 2017-2022 ($ Millions)

Figure 36. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales 2017-2022 (Kiloton)

Figure 37. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue 2017-2022 ($ Millions)

Figure 38. Americas Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2021

Figure 39. Americas Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2021

Figure 40. United States Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 41. Canada Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 42. Mexico Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 43. Brazil Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 44. APAC Nuclear Medicine/Radiopharmaceutic Sales Market Share by Region in 2021

Figure 45. APAC Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Regions in 2021

Figure 46. China Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 47. Japan Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 48. South Korea Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 49. Southeast Asia Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 50. India Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 51. Australia Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 52. Europe Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2021

Figure 53. Europe Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2021

Figure 54. Germany Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 55. France Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 56. UK Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 57. Italy Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 58. Russia Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 59. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Sales Market Share by Country in 2021

Figure 60. Middle East & Africa Nuclear Medicine/Radiopharmaceutic Revenue Market Share by Country in 2021

Figure 61. Egypt Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 62. South Africa Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 63. Israel Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 64. Turkey Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 65. GCC Country Nuclear Medicine/Radiopharmaceutic Revenue Growth 2017-2022 ($ Millions)

Figure 66. Manufacturing Cost Structure Analysis of Nuclear Medicine/Radiopharmaceutic in 2021

Figure 67. Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceutic

Figure 68. Industry Chain Structure of Nuclear Medicine/Radiopharmaceutic

Figure 69. Channels of Distribution

Figure 70. Distributors Profiles